Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework

BACKGROUND: Strong evidence supports administration of magnesium sulphate prior to birth at less than 30 weeks’ gestation to prevent very preterm babies dying or developing cerebral palsy. This study was undertaken as part of The WISH (Working to Improve Survival and Health for babies born very pret...

Descripción completa

Detalles Bibliográficos
Autores principales: Bain, Emily, Bubner, Tanya, Ashwood, Pat, Van Ryswyk, Emer, Simmonds, Lucy, Reid, Sally, Middleton, Philippa, Crowther, Caroline A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539663/
https://www.ncbi.nlm.nih.gov/pubmed/26283623
http://dx.doi.org/10.1186/s12884-015-0618-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539663/
https://www.ncbi.nlm.nih.gov/pubmed/26283623
http://dx.doi.org/10.1186/s12884-015-0618-9

Ejemplares similares